HTHT
ALNY icon

Hemenway Trust Hemenway Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,183
Closed -$277K – 144
2017
Q4 		$277K Sell
2,183
-615
-22% -$77.3K 0.05% 128
2017
Q3 		$329K Sell
2,798
-150
-5% -$12.8K 0.07% 99
2017
Q2 		$235K Buy
+2,948
New +$188K 0.05% 118
2017
Q1 		– Sell
-16,773
Closed -$628K – 130
2016
Q4 		$628K Buy
16,773
+3,373
+25% +$141K 0.16% 75
2016
Q3 		$908K Buy
13,400
+200
+2% +$14.1K 0.23% 68
2016
Q2 		$732K Buy
13,200
+525
+4% +$33.1K 0.19% 71
2016
Q1 		$796K Buy
12,675
+150
+1% +$9.97K 0.21% 67
2015
Q4 		$1.18M Hold
12,525
– – 0.31% 59
2015
Q3 		$1.01M Buy
12,525
+245
+2% +$27.2K 0.28% 64
2015
Q2 		$1.47M Buy
12,280
+150
+1% +$17.9K 0.38% 55
2015
Q1 		$1.27M Buy
12,130
+60
+0.5% +$6.08K 0.33% 57
2014
Q4 		$1.17M Buy
12,070
+40
+0.3% +$3.71K 0.35% 58
2014
Q3 		$940K Buy
12,030
+30
+0.3% +$1.94K 0.29% 61
2014
Q2 		$758K Hold
12,000
– – 0.23% 68
2014
Q1 		$806K Sell
12,000
-12,000
-50% -$929K 0.25% 63
2013
Q4 		$1.54M Sell
24,000
-6,000
-20% -$358K 0.49% 53
2013
Q3 		$1.92M Hold
30,000
– – 0.72% 46
2013
Q2 		$930K Buy
+30,000
New +$798K 0.4% 52

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Hemenway Trust Hemenway Trust's ALNY Position: Q1 2018 in Review

Hemenway Trust Hemenway Trust sold out of Alnylam Pharmaceuticals (ALNY) in Q1 2018, closing a stake of 2,183 shares — an estimated $277K sold.

Hemenway Trust Hemenway Trust first reported a position in ALNY in Q2 2013 and held it in 18 quarters. The position peaked at $1.92M in Q3 2013. 293 funds tracked by Wall St. Rank hold ALNY as of Q1 2018.

  • Hemenway Trust Hemenway Trust reported no remaining Alnylam Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 2,183 Alnylam Pharmaceuticals shares in Q1 2018, an estimated $277K.
  • Hemenway Trust Hemenway Trust first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Hemenway Trust Hemenway Trust's Alnylam Pharmaceuticals position peaked at $1.92M in Q3 2013.
  • 293 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2018.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2018, filed 24 Apr 2018.